The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

Appropriate patient selection for palliative chemotherapy is crucial in patients with metastatic colorectal cancer (mCRC). We investigated the prognostic value of C-reactive protein (CRP), derived neutrophil-to-lymphocyte ratio (dNLR), Interleukin (IL)-6, and YKL-40 on progression-free survival (PFS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liposits, Gabor, Skuladottir, Halla, Ryg, Jesper, Winther, Stine Brændegaard, Möller, Sören, Hofsli, Eva, Shah, Carl-Henrik, Poulsen, Laurids Østergaard, Berglund, Åke, Qvortrup, Camilla, Osterlund, Pia, Johansen, Julia S., Glimelius, Bengt, Sorbye, Halfdan, Pfeiffer, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571053/
https://www.ncbi.nlm.nih.gov/pubmed/36233472
http://dx.doi.org/10.3390/jcm11195603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571053/
https://www.ncbi.nlm.nih.gov/pubmed/36233472
http://dx.doi.org/10.3390/jcm11195603

Ejemplares similares